Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

RMD open

Showing results (591-600 of 1,920) with videos related to

Pageof 192
Sort By:
RMD Open|September 19, 2024
Attainment of EULAR/ERA-EDTA targets of therapy with current immunosuppressive regimens and adjustments in treatment: a multicentre, real-life observational studyMaria Pappa, Maria Kosmetatou, Antigone Pieta, et al.
RMD Open|September 21, 2024
Comparative early effectiveness across 14 PsA drugs and 5 classes of PsA treatment: 3-month results from the PRO-SPIRIT studyLars Erik Kristensen, Khai Jing Ng, Marcus Ngantcha, et al.
RMD Open|September 23, 2024
Predicting the risk of cardiovascular and cerebrovascular event in systemic lupus erythematosus: a Chinese SLE treatment and research group study XXVICan Huang, Yutong Li, Ziqian Wang, et al.
RMD Open|September 21, 2024
Autoantibodies, cutaneous subset and immunosuppressants contribute to the cancer risk in systemic sclerosisAntonio Tonutti, Francesca Motta, Natasa Isailovic, et al.
RMD Open|October 24, 2024
Depression, anxiety and cognitive function in persons with inflammatory rheumatic diseases: cross-sectional results from the German National Cohort (NAKO)Johanna Callhoff, Klaus Berger, Katinka Albrecht, et al.
RMD Open|November 7, 2024
Chronic kidney disease in patients with psoriatic arthritis: a cohort studyFadi Kharouf, Shangyi Gao, Shahad Al-Matar, et al.
RMD Open|November 3, 2024
Impact of patient characteristics on ASDAS disease activity state cut-offs in axial spondyloarthritis: results from nine European rheumatology registriesLykke M Ørnbjerg, Stylianos Georgiadis, Tore K Kvien, et al.
RMD Open|February 28, 2025
EducAR: implementing a multicomponent strategy to improve therapeutic adherence in rheumatoid arthritisMaría Ahijón Lana, Francisca Sivera Mascaró, Antonio Fernández-Nebro, et al.
RMD Open|February 23, 2025
Targeting the IL-17A pathway for therapy in early-stage tendinopathyNeal L Millar, Iain B McInnes, Frank Kolbinger, et al.
RMD Open|August 8, 2024
Impact of initiation of targeted therapy on the use of psoriatic arthritis-related treatments and healthcare consumption: a cohort study of 9793 patients from the French health insurance database (SNDS)Laura Pina Vegas, Siham Iggui, Emilie Sbidian, et al.
Pageof 192

Showing results (591-600 of 1,920) with videos related to

Sort By:
Pageof 192
RMD Open|September 19, 2024
Attainment of EULAR/ERA-EDTA targets of therapy with current immunosuppressive regimens and adjustments in treatment: a multicentre, real-life observational studyMaria Pappa, Maria Kosmetatou, Antigone Pieta, et al.
RMD Open|September 21, 2024
Comparative early effectiveness across 14 PsA drugs and 5 classes of PsA treatment: 3-month results from the PRO-SPIRIT studyLars Erik Kristensen, Khai Jing Ng, Marcus Ngantcha, et al.
RMD Open|September 23, 2024
Predicting the risk of cardiovascular and cerebrovascular event in systemic lupus erythematosus: a Chinese SLE treatment and research group study XXVICan Huang, Yutong Li, Ziqian Wang, et al.
RMD Open|September 21, 2024
Autoantibodies, cutaneous subset and immunosuppressants contribute to the cancer risk in systemic sclerosisAntonio Tonutti, Francesca Motta, Natasa Isailovic, et al.
RMD Open|October 24, 2024
Depression, anxiety and cognitive function in persons with inflammatory rheumatic diseases: cross-sectional results from the German National Cohort (NAKO)Johanna Callhoff, Klaus Berger, Katinka Albrecht, et al.
RMD Open|November 7, 2024
Chronic kidney disease in patients with psoriatic arthritis: a cohort studyFadi Kharouf, Shangyi Gao, Shahad Al-Matar, et al.
RMD Open|November 3, 2024
Impact of patient characteristics on ASDAS disease activity state cut-offs in axial spondyloarthritis: results from nine European rheumatology registriesLykke M Ørnbjerg, Stylianos Georgiadis, Tore K Kvien, et al.
RMD Open|February 28, 2025
EducAR: implementing a multicomponent strategy to improve therapeutic adherence in rheumatoid arthritisMaría Ahijón Lana, Francisca Sivera Mascaró, Antonio Fernández-Nebro, et al.
RMD Open|February 23, 2025
Targeting the IL-17A pathway for therapy in early-stage tendinopathyNeal L Millar, Iain B McInnes, Frank Kolbinger, et al.
RMD Open|August 8, 2024
Impact of initiation of targeted therapy on the use of psoriatic arthritis-related treatments and healthcare consumption: a cohort study of 9793 patients from the French health insurance database (SNDS)Laura Pina Vegas, Siham Iggui, Emilie Sbidian, et al.
Pageof 192